Werbung
Werbung

DHCNL

DHCNL logo

Diversified Healthcare Trust 6.25% Senior Notes Due 2046

17.90
USD
Gesponsert
+0.09
+0.51%
09. Jan., 15:05 UTC -5
Geschlossen
exchange

Nach-Markt

17.90

0.00
0.00%

DHCNL Ergebnisberichte

Positives Überraschungsverhältnis

DHCNL übertreffen die 13 der letzten 40Schätzungen.

33%

Nächster Bericht

Datum des nächsten Berichts
23. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$396.82M
/
-$0.17
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+2.09%
/
-75.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+4.53%
/
-52.78%

Diversified Healthcare Trust 6.25% Senior Notes Due 2046 earnings per share and revenue

On 03. Nov. 2025, DHCNL reported earnings of -0.68 USD per share (EPS) for Q3 25, missing the estimate of -0.21 USD, resulting in a -213.08% surprise. Revenue reached 388.71 million, compared to an expected 386.12 million, with a 0.67% difference. The market reacted with a -0.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.17 USD, with revenue projected to reach 396.82 million USD, implying an decrease of -75.00% EPS, and increase of 2.09% in Revenue from the last quarter.
FAQ
For Q3 2025, Diversified Healthcare Trust 6.25% Senior Notes Due 2046 reported EPS of -$0.68, missing estimates by -213.08%, and revenue of $388.71M, 0.67% above expectations.
The stock price moved down -0.03%, changed from $17.98 before the earnings release to $17.97 the day after.
The next earning report is scheduled for 23. Feb. 2026.
Based on 3 analysts, Diversified Healthcare Trust 6.25% Senior Notes Due 2046 is expected to report EPS of -$0.17 and revenue of $396.82M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung